FDA extends approval of dapagliflozin to Childers for treatment of type 2 diabetes Dr. Kamal Kant Kohli19 Jun 2024 8:00 PM ISTThe US food and Drug Administration has approved dapagliflozin for treatment of children and adolescents with type 2 diabetes as an add-on treatment...
AstraZeneca Farxiga gets USFDA nod for paediatric type 2 diabetes Ruchika Sharma14 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) for the improvement of...
AstraZeneca Farxiga approved in US to reduce risk of cardiovascular death, hospitalisation for heart failure to broader range of patients Ruchika Sharma10 May 2023 12:30 PM ISTCambridge: AstraZeneca has announced that Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death,...
AstraZeneca Farxiga gets approval in US for CKD prevention Ruchika Sharma2 May 2021 9:30 AM ISTUK: AstraZeneca's Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of...
FDA Approves dapagliflozin for treating Chronic Kidney Disease Dr Kartikeya Kohli1 May 2021 7:46 AM ISTThe U.S. Food and Drug Administration has approved dapagliflozin oral tablets to reduce the risk of kidney function decline, kidney failure,...
Diabetes drug Farxiga fails in trial to treat covid patients: AstraZeneca Ruchika Sharma12 April 2021 6:10 PM ISTUK: Data from a late-stage study to test if AstraZeneca's diabetes drug Farxiga could treat patients hospitalised with COVID-19 and at risk of...
Dapagliflozin going off-patent- NPPA brings Dapagliflozin, Metformin Combination under price control Farhat Nasim14 Jan 2021 5:15 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin going off-patent, the apex drug price regulator, National Pharmaceutical Pricing...
AstraZeneca gets USFDA Priority Review for Farxiga to treat chronic kidney disease Ruchika Sharma7 Jan 2021 12:00 PM ISTCKD, a condition defined by decreased kidney function, is often associated with a heightened risk of heart disease or stroke, or the need for dialysis...
Price war over Diabetes drug Dapagliflozin: AstraZeneca drags 12 drugmakers to Delhi court Farhat Nasim16 Oct 2020 5:30 PM ISTNew Delhi: Proclaiming a legal battle against 12 Indian drugmakers, AstraZeneca has moved Delhi high court against the dozen firms for eyeing to roll...
